Рейтинг компаний по расходам на R&D
|
№
|
Short Name
|
R&D расходы, $
|
|
1
|
ROCHE HLDG-GENUS
|
10,919,999,078
|
|
2
|
NOVARTIS AG-REG
|
9,086,000,128
|
|
3
|
JOHNSON&JOHNSON
|
8,494,000,128
|
|
4
|
PFIZER INC
|
8,392,999,936
|
|
5
|
MERCK & CO
|
7,180,000,256
|
|
6
|
SANOFI
|
6,408,626,712
|
|
7
|
GLAXOSMITHKLINE
|
5,683,438,585
|
|
8
|
ASTRAZENECA PLC
|
5,578,999,808
|
|
9
|
ELI LILLY & CO
|
4,733,599,744
|
|
10
|
BRISTOL-MYER SQB
|
4,534,000,128
|
|
11
|
AMGEN INC
|
4,296,999,936
|
|
12
|
TAKEDA PHARMACEU
|
3,493,223,986
|
|
13
|
ABBVIE INC
|
3,296,999,936
|
|
14
|
GILEAD SCIENCES
|
2,854,000,128
|
|
15
|
OTSUKA HOLDINGS
|
2,486,434,278
|
|
16
|
NOVO NORDISK-B
|
2,452,338,082
|
|
17
|
CELGENE CORP
|
2,430,599,936
|
|
18
|
MERCK KGAA
|
2,263,345,175
|
|
19
|
BIOGEN INC
|
1,893,421,952
|
|
20
|
ASTELLAS PHARMA
|
1,888,772,663
|
|
21
|
DAIICHI SANKYO
|
1,743,101,324
|
|
22
|
REGENERON PHARM
|
1,271,352,960
|
Источник: Bloomberg